Literature DB >> 19296981

Patients with primary hyperparathyroidism--why do some form stones?

Aaron D Berger1, Wilfred Wu, Brian H Eisner, Matthew R Cooperberg, Quan-Yang Duh, Marshall L Stoller.   

Abstract

PURPOSE: Primary hyperparathyroidism is a common cause of hypercalcemia with resulting hypercalciuria and a subset of these patients with primary hyperparathyroidism present with urolithiasis. We evaluated the metabolic stone profile in patients presenting for parathyroid surgery and determined whether there were differences between those with and without a history of urinary stones.
MATERIALS AND METHODS: A total of 60 patients with primary hyperparathyroidism presenting for parathyroid surgery were prospectively enrolled in the study, of whom 54 completed a preoperative 24-hour urine collection. Of these 54 patients 27 completed an additional postoperative 24-hour urine collection. We compared preoperative metabolic urinary profiles and serum calcium in patients with primary hyperparathyroidism with and without a history of urolithiasis. In addition, we compared changes in urine metabolic profiles that occurred after successful parathyroid surgery.
RESULTS: There were no significant differences in preoperative 24-hour urine metabolic profiles or serum calcium between patients who had primary hyperparathyroidism with and without a history of urolithiasis. Compared to preoperative levels after successful parathyroid surgery there were significant decreases in serum calcium (10.8 to 9.3 mg/dl, p <0.001), urinary calcium (319 to 156 mg per day, p <0.01) calcium oxalate supersaturation (8.6 to 5.7, p = 0.016) and calcium phosphate supersaturation (1.6 to 0.9, p = 0.002) in the 27 patients who completed a postoperative 24-hour urine collection.
CONCLUSIONS: Other etiological factors must exist that cause some patients with primary hyperparathyroidism to form stones, while most never have stones despite profound hypercalcemia and hypercalciuria. Routine 24-hour urine evaluation cannot predict which patients with primary hyperparathyroidism will have kidney stones.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19296981     DOI: 10.1016/j.juro.2009.01.028

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  13 in total

1.  Occult urolithiasis in asymptomatic primary hyperparathyroidism.

Authors:  Yu-Kwang Donovan Tay; Minghao Liu; Leonardo Bandeira; Mariana Bucovsky; James A Lee; Shonni J Silverberg; Marcella D Walker
Journal:  Endocr Res       Date:  2018-02-05       Impact factor: 1.720

2.  Hypercalciuria: its value as a predictive risk factor for nephrolithiasis in asymptomatic primary hyperparathyroidism?

Authors:  F Saponaro; F Cetani; L Mazoni; M Apicella; M Di Giulio; F Carlucci; M Scalese; E Pardi; S Borsari; J P Bilezikian; C Marcocci
Journal:  J Endocrinol Invest       Date:  2019-12-23       Impact factor: 4.256

3.  Recurrent urolithiasis following parathyroidectomy for primary hyperparathyroidism.

Authors:  C Rowlands; A Zyada; S Zouwail; H Joshi; M J Stechman; D M Scott-Coombes
Journal:  Ann R Coll Surg Engl       Date:  2013-10       Impact factor: 1.891

4.  24-hour urinary calcium in primary hyperparathyroidism.

Authors:  Carrie E Black; Richard L Berg; Andrew C Urquhart
Journal:  Clin Med Res       Date:  2013-12

5.  Severe obesity is associated with symptomatic presentation, higher parathyroid hormone levels, and increased gland weight in primary hyperparathyroidism.

Authors:  Mohamed Abdelgadir Adam; Brian R Untch; Melissa E Danko; Sandra Stinnett; Darshana Dixit; James Koh; Jeffrey R Marks; John A Olson
Journal:  J Clin Endocrinol Metab       Date:  2010-08-04       Impact factor: 5.958

6.  Commentary on silent renal stones in primary hyperparathyroidism: prevalence and clinical features.

Authors:  Cristiana Cipriani; John P Bilezikian
Journal:  Endocr Pract       Date:  2014-11       Impact factor: 3.443

7.  Persistence of hypercalciuria after successful surgical treatment for primary hyperparathyroidism.

Authors:  Francisco Rodolfo Spivacow; Armando Luis Negri; Elisa Elena del Valle; Erich Fradinger; Carolina Martinez; Ana Polonsky
Journal:  Int Urol Nephrol       Date:  2011-04-20       Impact factor: 2.370

8.  Clinical presentation and management of patients with primary hyperparathyroidism of the Swiss Primary Hyperparathyroidism Cohort: a focus on neuro-behavioral and cognitive symptoms.

Authors:  A Trombetti; E R Christ; C Henzen; G Gold; M Brändle; F R Herrmann; C Torriani; F Triponez; M Kraenzlin; R Rizzoli; C Meier
Journal:  J Endocrinol Invest       Date:  2016-01-07       Impact factor: 4.256

Review 9.  Primary hyperparathyroidism.

Authors:  Marcella D Walker; Shonni J Silverberg
Journal:  Nat Rev Endocrinol       Date:  2017-09-08       Impact factor: 43.330

10.  Pathologic fractures: a neglected clinical feature of parathyroid adenoma.

Authors:  Hassan Abshirini; Iran Rashidi; Nader Saki
Journal:  Case Rep Med       Date:  2010-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.